Fluvirin 2017 - 2018 Flu Vaccine 45 mcg / 0.5 mL Indicated For People 4 Years of Age and Above Multiple Dose Vial 5 mL Seqirus 70461012010

Fluvirin 2017 - 2018 Flu Vaccine 45 mcg / 0.5 mL Indicated For People 4 Years of Age and Above Multiple Dose Vial 5 mL Seqirus 70461012010

TERMS & CONDITIONS FOR PURCHASING INJECTABLES & MEDICATIONS : 1- REGULATIONS ON PURCHASE OF INJECTABLES & MEDICATIONS VARY FROM STATE TO STATE . IT IS THE PURCHASER'S RESPONSIBILITY TO KNOW AND COMPLY WITH THE LAWS GOVERNING THE DISTRICT IN WHICH THEY LIVE. 2- INJECTABLES & MEDICATIONS WOULD BE SOLD ONLY TO QUALIFIED CUSTOMERS ( PHYSICIAN OFFICES , DIAGNOSTIC & RESEARCH LABORATORIES , DENTAL OFFICES , HEALTH CARE PROVIDERS , .... ) WITH VALID MEDICAL LICENSE. 3- ORDERS INCLUDING PURCHSE OF INJECTABLES & MEDICATIONS WOULD BE PROCESSED AFTER VERIFICATION OF PURCHASER'S VALID MEDICAL LICENSE TO BE EMAILED AS AN ATTACHMENT TO : ADMIN@ALLMEDTECH.COM OR FAXED TO 323-782-0985 )

Manufacturer # 70461012010 Brand Fluvirin® 2017 - 2018 Manufacturer Seqirus USA Inc Application Flu Vaccine Container Type Multiple Dose Vial Dosage Form Injection Generic Drug Code 43472 NDC Number 70461-0120-10 Storage Requirements Requires Refrigeration Strength 45 mcg / 0.5 mL Type Intramuscular User Indicated For People 4 Years of Age and Above Volume 5 mL

Features

FLUVIRIN® is an inactivated influenza virus vaccine indicated for active immunization of persons 4 years of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine FLUVIRIN® is a trivalent, sub-unit (purified surface antigen) influenza virus vaccine prepared from virus propagated in the allantoic cavity of embryonated hens' eggs inoculated with a specific type of influenza virus suspension containing neomycin and polymyxin FLUVIRIN® has been standardized according to USPHS requirements for the 2017/2018 influenza season and is formulated to contain 45 mcg hemagglutinin (HA) per 0.5-mL dose in the recommended ratio of 15 mcg HA of each of the following 3 viruses:A/Singapore/GP1908/2015,IVR-180 (an A/Michigan/45/2015 (H1N1)pdm09- like virus; A/Hong Kong/4801/2014, NYMC X-263B (H3N2) (an A/Hong Kong/4801/2014- like virus); and B/Brisbane/60/2008, wild type (a B/Brisbane/60/2008-like virus) The 5-mL multidose vial formulation contains thimerosal, a mercury derivative, added as a preservative